Answers are grounded in this paper and cite their sources.
In the present study, Pušnik et al. investigated whether the XBB.1.5-adapted booster can overcome the persistent imprinting of SARS-CoV-2 immunity by wild-type based vaccines. The findings demonstrate increased plasma neutralization against the homologous variant following the booster vaccination. Formation of de novo humoral response against the mutated epitopes of XBB.1.5 variant's surface proteins was observed in 3/20 individuals. The booster vaccination had no significant effect on T-cell response.
No takes yet. Share an insight, caveat, or question.
Pušnik et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: